Sponsor Pipeline

NovelMed Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
8
Active Trials
0
Recruiting
Active Trials by Phase
Phase 2
7
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT05646524 Study of Efficacy and Safety of NM8074 in Adult PNH Patients Who Are Naive to Complement… Paroxysmal Nocturnal Hemoglobinuria Not Yet Recruiting
NCT06226662 Study of NM8074 in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated… Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Not Yet Recruiting
NCT06887738 Study of NM8074 in Patients with Dermatomyositis (DM) Dermatomyositis Not Yet Recruiting
NCT05731050 Study of NM8074 in Soliris-Treated Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) PNH - Paroxysmal Nocturnal Hemoglobinuria Not Yet Recruiting
NCT05646563 Study of NM8074 in Adult PNH Patients With Inadequate Response to Soliris Paroxysmal Nocturnal Hemoglobinuria Not Yet Recruiting
NCT05684159 Study of NM8074 in Patients With aHUS With Evidence of Ongoing Thrombotic Microangiopathy aHUS - Atypical Hemolytic Uremic Syndrome Not Yet Recruiting
NCT06454110 Study of NM8074 in Patients With Immunoglobulin A Nephropathy (IgAN) IgA Nephropathy Not Yet Recruiting
Phase 1/2
NCT05647811 Study of NM8074 in Adult C3 Glomerulopathy Patients C3 Glomerulopathy Not Yet Recruiting
Get alerts when NovelMed Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free